【Blueberry Therapeutics-Product BB2603】Blueberry Therapeutics Announce Positive Results from a Phase I/II Clinical Trial

3^rd January 2019- Helius Medical Technologies, Inc. issued an announcement, which is summarized as follows：

Helius Medical Technologies, Inc. announced that its wholly owned subsidiary, NeuroHabilitation Corporation, has partnered with Kessler Institute for Rehabilitation and Kessler Foundation, New Jersey-based leaders in rehabilitation care and research, to implement its fourth Clinical Experience Program (CEP) for PoNS^?.

The original website link：

https://heliusmedical.com/index.php/newsroom/news-release/2019/260-